Nkmax Co., Ltd.
Overview
Nkmax Co., Ltd. is a South Korean biotechnology company that focuses on the development and commercialization of immunotherapeutic products. The company specializes primarily in natural killer (NK) cell therapies and aims to harness the power of the immune system to treat various diseases, including cancer.
Therapeutic areas
FDA compliance signals
No FDA recalls, Warning Letters, or Form 483 observations are linked to Nkmax Co., Ltd. in our records. Events are linked by company name and identifier, so this is not proof that none exist; check the FDA's own databases before relying on it.
Is this Nkmax Co., Ltd.?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.
Need suppliers found and checked?
The Sourcing Desk turns these records into a checked shortlist: current filings, site, grade and regulatory history confirmed for your product, for a buyer-paid fixed fee and no supplier commission.